Results 121 to 130 of about 3,296 (215)

Topical Treatment of Actinic Keratosis and Non-melanoma Skin Cancer with Phospho-sulindac and Difluoromethylornithine

open access: yes, 2015
Actinic keratosis (AK), a cutaneous lesion resulting from the proliferation of atypical epidermal keratinocytes, has an incidence of 11%-26% and its prevalence is 58 million in the US alone. AK is a precursor to non-melanoma skin cancer (NMSC).
Sun, Yajing
core  

Discovery of Anthranilic Acid Derivatives as Difluoromethylornithine Adjunct Agents That Inhibit Far Upstream Element Binding Protein 1 (FUBP1) Function

open access: yes
Polyamine biosynthesis is regulated by ornithine decarboxylase (ODC), which is transcriptionally activated by c-Myc. A large library was screened to find molecules that potentiate the ODC inhibitor, difluoromethylornithine (DFMO).
Juan Pablo Arnoletti (12275290)   +15 more
core   +1 more source

Polyamine Depletion by D,L-α-Difluoromethylornithine Inhibits Ewing Sarcoma Metastasis by Inducing Ferroptosis. [PDF]

open access: yesClin Cancer Res
Offenbacher R   +11 more
europepmc   +1 more source

Polyamines stimulate the protein synthesis of the translation initiation factor eIF5A2, participating in mRNA decoding, distinct from eIF5A1. [PDF]

open access: yesJ Biol Chem
Suzuki M   +15 more
europepmc   +1 more source

Recent Trends in Clinical Trials for Pediatric Sarcoma in the United States: An Analysis of ClinicalTrials.gov. [PDF]

open access: yesChildren (Basel)
Alkhawaldeh K   +8 more
europepmc   +1 more source

Chemoprevention in Skin Cancer: What Advice? [PDF]

open access: yesCancers (Basel)
Ortiz-Brugués A   +9 more
europepmc   +1 more source

Reprogramming neuroblastoma by diet-enhanced polyamine depletion. [PDF]

open access: yesNature
Cherkaoui S   +21 more
europepmc   +1 more source

Polyamine Inhibition with DFMO: Shifting the Paradigm in Neuroblastoma Therapy. [PDF]

open access: yesJ Clin Med
Schramm J   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy